{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:07:17Z","timestamp":1790694437935,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.14283\/jpad.2024.15","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T08:51:58Z","timestamp":1704876718000},"page":"414-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"A.C.","family":"Macedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.P.A.","family":"Dur\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.O.","family":"Vilela de Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Aumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Servaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fernandez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.Z.","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.R.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2024.15_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group* under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.15_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1445-5994.2006.01153.x","article-title":"Tauopathies: Classification and Clinical Update on Neurodegenerative Diseases Associated with Microtubule-Associated Protein","volume":"36","author":"Williams","year":"2006","journal-title":"Tau. Intern. Med. J"},{"key":"10.14283\/jpad.2024.15_bib3","doi-asserted-by":"crossref","first-page":"53562","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a Biological Definition of Alzheimer's Disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.15_bib4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","article-title":"Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework","volume":"76","author":"Jack","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2024.15_bib5","article-title":"Frequency of Biologically-Defined AD in Relation to Age, Sex, APOE\u03b54 and Cognitive Impairment","author":"Therriault","year":"2020","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.15_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological Stageing of Alzheimer-Related Changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.14283\/jpad.2024.15_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer Disease-Associated Neurofibrillary Pathology Using Paraffin Sections and Immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.14283\/jpad.2024.15_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET Imaging of Tau Deposition in the Aging Human Brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"10.14283\/jpad.2024.15_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically Defined Subtypes of Alzheimer's Disease with Distinct Clinical Characteristics: A Retrospective Study","volume":"10","author":"Murray","year":"2011","journal-title":"The Lancet Neurology"},{"key":"10.14283\/jpad.2024.15_bib10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","article-title":"The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework","volume":"64","author":"Macedo","year":"2023","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00687663","article-title":"Quantitative Histological Studies on the Aged Human Brain: I. Senile Plaques and Neurofibrillary Tangles in?Normal? Patients","volume":"16","author":"Dayan","year":"1970","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.14283\/jpad.2024.15_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2990.1990.tb00940.x","article-title":"A Quantitative Histological Study of Early Clinical and Preclinical Alzheimer's Disease. Neuropathol","volume":"16","author":"Hubbard","year":"1990","journal-title":"Appl. Neurobiol"},{"key":"10.14283\/jpad.2024.15_bib13","series-title":"Senile Dementia: A Biomedical Approach","first-page":"105","article-title":"Senile Dementia: A Focal Disease in the Temporal Lobe","author":"Kemper","year":"1978"},{"key":"10.14283\/jpad.2024.15_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0022-510X(82)90155-1","article-title":"Plaques, Tangles and Dementia","volume":"56","author":"Wilcock","year":"1982","journal-title":"J. Neurol. Sci"},{"key":"10.14283\/jpad.2024.15_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","article-title":"An Autoradiographic Evaluation of AV-1451 Tau PET in Dementia","volume":"4","author":"Lowe","year":"2016","journal-title":"Acta Neuropathol. Commun"},{"key":"10.14283\/jpad.2024.15_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating Novel Tau Positron Emission Tomography Tracer [F-18]-AV-1451 (T807) on Postmortem Brain Tissue: Validation of PET Tracer","volume":"78","author":"Marqui\u00e9","year":"2015","journal-title":"Ann. Neurol"},{"key":"10.14283\/jpad.2024.15_bib17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","article-title":"Characterization of Tau Positron Emission Tomography Tracer [18 F]AV-1451 Binding to Postmortem Tissue in Alzheimer's Disease, Primary Tauopathies, and Other Dementias","volume":"12","author":"Sander","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.15_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","article-title":"Autoradiography Validation of Novel Tau PET Tracer [F-18]-MK-6240 on Human Postmortem Brain Tissue","volume":"7","author":"Aguero","year":"2019","journal-title":"Acta Neuropathol. Commun"},{"key":"10.14283\/jpad.2024.15_bib19","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET Imaging in Neurodegenerative Tauopathies\u2014Still a Challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.14283\/jpad.2024.15_bib20","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.2967\/jnumed.121.263196","article-title":"Tau PET Imaging in Neurodegenerative Disorders","volume":"63","author":"Groot","year":"2022","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib21","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2967\/jnumed.118.209916","article-title":"Characterization of 3 Novel Tau Radiopharmaceuticals, 11 C-RO-963, 11 C-RO-643, and 18 F-RO-948, in Healthy Controls and in Alzheimer Subjects","volume":"59","author":"Wong","year":"2018","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2967\/jnumed.118.214437","article-title":"Evaluation of 18 F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain","volume":"59","author":"Kuwabara","year":"2018","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib23","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","article-title":"Preclinical Characterization of 18 F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles","volume":"57","author":"Hostetler","year":"2016","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","article-title":"In Vivo Quantification of Neurofibrillary Tangles with [18F]MK-6240","volume":"10","author":"Pascoal","year":"2018","journal-title":"Alzheimers Res. Ther"},{"key":"10.14283\/jpad.2024.15_bib25","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/brain\/awaa180","article-title":"18F-MK-6240 PET for Early and Late Detection of Neurofibrillary Tangles","volume":"143","author":"Pascoal","year":"2020","journal-title":"Brain"},{"key":"10.14283\/jpad.2024.15_bib26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional Profiles of the Candidate Tau PET Ligand 18 F-AV-1451 Recapitulate Key Features of Braak Histopathological Stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"key":"10.14283\/jpad.2024.15_bib27","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2967\/jnumed.118.221697","article-title":"Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study","volume":"60","author":"Cho","year":"2019","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of Multiple Tau-PET Measures as Biomarkers in Aging and Alzheimer's Disease","volume":"157","author":"Maass","year":"2017","journal-title":"NeuroImage"},{"key":"10.14283\/jpad.2024.15_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-215024","article-title":"Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum","volume":"85","author":"Nihashi","year":"2022","journal-title":"J. Alzheimers Dis"},{"key":"10.14283\/jpad.2024.15_bib30","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18 F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease","volume":"54","author":"Okamura","year":"2013","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine Oxidase B Inhibitor, Selegiline, Reduces 18F-THK5351 Uptake in the Human Brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res. Ther"},{"key":"10.14283\/jpad.2024.15_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2967\/jnumed.117.197426","article-title":"Correlations of 18 F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease","volume":"59","author":"Harada","year":"2018","journal-title":"J. Nucl. Med"},{"key":"10.14283\/jpad.2024.15_bib33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/alz.12384","article-title":"Patterns of Tau Pathology Identified with 18 F-MK-6240 PET Imaging","volume":"18","author":"Kreisl","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.15_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-201457","article-title":"Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment","volume":"82","author":"King-Robson","year":"2021","journal-title":"J. Alzheimers Dis"},{"key":"10.14283\/jpad.2024.15_bib35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/biom12030458","article-title":"Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease","volume":"12","author":"Rullmann","year":"2022","journal-title":"Biomolecules"},{"key":"10.14283\/jpad.2024.15_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker Modeling of Alzheimer's Disease Using PET-Based Braak Staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat. Aging"},{"key":"10.14283\/jpad.2024.15_bib37","doi-asserted-by":"crossref","first-page":"fcad146","DOI":"10.1093\/braincomms\/fcad146","article-title":"Verbal Memory Formation across PET-Based Braak Stages of Tau Accumulation in Alzheimer's Disease","volume":"5","author":"Arias","year":"2023","journal-title":"Brain Commun"},{"key":"10.14283\/jpad.2024.15_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2024.15_bib39","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1093\/brain\/awab248","article-title":"Longitudinal 18F-MK-6240 Tau Tangles Accumulation Follows Braak Stages","volume":"144","author":"Pascoal","year":"2021","journal-title":"Brain"},{"key":"10.14283\/jpad.2024.15_bib40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopsych.2020.01.023","article-title":"Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease","volume":"89","author":"Pichet Binette","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.14283\/jpad.2024.15_bib41","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/gps.5459","article-title":"for the Alzheimer's Disease Neuroimaging Initiative Relationship between Neuropsychiatric Symptoms and Alzheimer's Disease Pathology: An in Vivo Positron Emission Tomography Study","volume":"36","author":"Yasuno","year":"2021","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.14283\/jpad.2024.15_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000110738","article-title":"Neuropsychiatric Syndromes in Dementia","volume":"24","author":"Aalten","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.14283\/jpad.2024.15_bib43","article-title":"Association between Regional Tau Pathology and Neuropsychiatric Symptoms in Aging and Dementia Due to Alzheimer's Disease","volume":"7","author":"Tissot","year":"2021","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv"},{"key":"10.14283\/jpad.2024.15_bib44","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and Behavioral Disturbances in Dementia: Findings From the Cache County Study on Memory in Aging","author":"Lyketsos","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.14283\/jpad.2024.15_bib45","unstructured":"Mega, M.S.; Cummings, J.L.; Fiorello, T.; Gornbein, J. The Spectrum of Behavioral Changes in Alzheimer's."},{"key":"10.14283\/jpad.2024.15_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/alz.12007","article-title":"Mild Behavioral Impairment Is Associated with B-amyloid but Not Tau or Neurodegeneration in Cognitively Intact Elderly Individuals","volume":"16","author":"Lussier","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.15_bib47","article-title":"Intrinsic Connectivity of the Human Brain Provides Scaffold for Tau Aggregation in Clinical Variants of Alzheimer's Disease. Sci. Transl","year":"2022","journal-title":"Med"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T18:36:48Z","timestamp":1736447808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2274580724000888"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.15","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.15","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}